CEFTRIAXONE VERSUS AMPICILLIN AND CHLORAMPHENICOL FOR TREATMENT OF BACTERIAL MENINGITIS IN CHILDREN

MariaDeLosA Del Rio, Sharon Shelton, Dale Chrane, GeorgeH Mccracken, JohnD Nelson

Research output: Contribution to journalArticle

137 Citations (Scopus)

Abstract

78 patients with bacterial meningitis were evaluated in a prospective, randomised study comparing twice-daily ceftriaxone as single-drug therapy with ampicillin and chloramphenicol given every 6 h. The groups were comparable in age, sex, days of illness before admission, and bacterial colony counts in cerebrospinal fluid (CSF). The pathogens were Haemophilus influenzae type b (54 cases), streptococci (9 cases), meningococci (9 cases), and unknown (6 cases). In 40 CSF specimens obtained 4-12 h after initiation of therapy, cultures were negative in 57% of the ceftriaxone patients and in 42% of the others. The mean falls in the CSF bacterial colony counts were 4.7 and 5.0 log10 colony-forming units/ml, respectively. Mean bactericidal activity in CSF was significantly greater in the ceftriaxone than in the conventional treatment group at the beginning and end of therapy. There were no significant differences in clinical responses or in frequency of complications, except for mild diarrhoea, which occurred in 16 ceftriaxone patients and in 8 in the other group (p<0·05).

Original languageEnglish (US)
Pages (from-to)1241-1244
Number of pages4
JournalThe Lancet
Volume321
Issue number8336
DOIs
StatePublished - Jun 4 1983

Fingerprint

Bacterial Meningitides
Ceftriaxone
Chloramphenicol
Ampicillin
Cerebrospinal Fluid
Bacterial Load
Haemophilus influenzae type b
Sick Leave
Neisseria meningitidis
Therapeutics
Streptococcus
Diarrhea
Stem Cells
Prospective Studies
Drug Therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

CEFTRIAXONE VERSUS AMPICILLIN AND CHLORAMPHENICOL FOR TREATMENT OF BACTERIAL MENINGITIS IN CHILDREN. / Del Rio, MariaDeLosA; Shelton, Sharon; Chrane, Dale; Mccracken, GeorgeH; Nelson, JohnD.

In: The Lancet, Vol. 321, No. 8336, 04.06.1983, p. 1241-1244.

Research output: Contribution to journalArticle

Del Rio, MariaDeLosA ; Shelton, Sharon ; Chrane, Dale ; Mccracken, GeorgeH ; Nelson, JohnD. / CEFTRIAXONE VERSUS AMPICILLIN AND CHLORAMPHENICOL FOR TREATMENT OF BACTERIAL MENINGITIS IN CHILDREN. In: The Lancet. 1983 ; Vol. 321, No. 8336. pp. 1241-1244.
@article{0d9e72c26c1645e5b4317bcf4b1fc574,
title = "CEFTRIAXONE VERSUS AMPICILLIN AND CHLORAMPHENICOL FOR TREATMENT OF BACTERIAL MENINGITIS IN CHILDREN",
abstract = "78 patients with bacterial meningitis were evaluated in a prospective, randomised study comparing twice-daily ceftriaxone as single-drug therapy with ampicillin and chloramphenicol given every 6 h. The groups were comparable in age, sex, days of illness before admission, and bacterial colony counts in cerebrospinal fluid (CSF). The pathogens were Haemophilus influenzae type b (54 cases), streptococci (9 cases), meningococci (9 cases), and unknown (6 cases). In 40 CSF specimens obtained 4-12 h after initiation of therapy, cultures were negative in 57{\%} of the ceftriaxone patients and in 42{\%} of the others. The mean falls in the CSF bacterial colony counts were 4.7 and 5.0 log10 colony-forming units/ml, respectively. Mean bactericidal activity in CSF was significantly greater in the ceftriaxone than in the conventional treatment group at the beginning and end of therapy. There were no significant differences in clinical responses or in frequency of complications, except for mild diarrhoea, which occurred in 16 ceftriaxone patients and in 8 in the other group (p<0·05).",
author = "{Del Rio}, MariaDeLosA and Sharon Shelton and Dale Chrane and GeorgeH Mccracken and JohnD Nelson",
year = "1983",
month = "6",
day = "4",
doi = "10.1016/S0140-6736(83)92696-X",
language = "English (US)",
volume = "321",
pages = "1241--1244",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8336",

}

TY - JOUR

T1 - CEFTRIAXONE VERSUS AMPICILLIN AND CHLORAMPHENICOL FOR TREATMENT OF BACTERIAL MENINGITIS IN CHILDREN

AU - Del Rio, MariaDeLosA

AU - Shelton, Sharon

AU - Chrane, Dale

AU - Mccracken, GeorgeH

AU - Nelson, JohnD

PY - 1983/6/4

Y1 - 1983/6/4

N2 - 78 patients with bacterial meningitis were evaluated in a prospective, randomised study comparing twice-daily ceftriaxone as single-drug therapy with ampicillin and chloramphenicol given every 6 h. The groups were comparable in age, sex, days of illness before admission, and bacterial colony counts in cerebrospinal fluid (CSF). The pathogens were Haemophilus influenzae type b (54 cases), streptococci (9 cases), meningococci (9 cases), and unknown (6 cases). In 40 CSF specimens obtained 4-12 h after initiation of therapy, cultures were negative in 57% of the ceftriaxone patients and in 42% of the others. The mean falls in the CSF bacterial colony counts were 4.7 and 5.0 log10 colony-forming units/ml, respectively. Mean bactericidal activity in CSF was significantly greater in the ceftriaxone than in the conventional treatment group at the beginning and end of therapy. There were no significant differences in clinical responses or in frequency of complications, except for mild diarrhoea, which occurred in 16 ceftriaxone patients and in 8 in the other group (p<0·05).

AB - 78 patients with bacterial meningitis were evaluated in a prospective, randomised study comparing twice-daily ceftriaxone as single-drug therapy with ampicillin and chloramphenicol given every 6 h. The groups were comparable in age, sex, days of illness before admission, and bacterial colony counts in cerebrospinal fluid (CSF). The pathogens were Haemophilus influenzae type b (54 cases), streptococci (9 cases), meningococci (9 cases), and unknown (6 cases). In 40 CSF specimens obtained 4-12 h after initiation of therapy, cultures were negative in 57% of the ceftriaxone patients and in 42% of the others. The mean falls in the CSF bacterial colony counts were 4.7 and 5.0 log10 colony-forming units/ml, respectively. Mean bactericidal activity in CSF was significantly greater in the ceftriaxone than in the conventional treatment group at the beginning and end of therapy. There were no significant differences in clinical responses or in frequency of complications, except for mild diarrhoea, which occurred in 16 ceftriaxone patients and in 8 in the other group (p<0·05).

UR - http://www.scopus.com/inward/record.url?scp=0020530028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020530028&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(83)92696-X

DO - 10.1016/S0140-6736(83)92696-X

M3 - Article

C2 - 6134039

AN - SCOPUS:0020530028

VL - 321

SP - 1241

EP - 1244

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8336

ER -